To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Newbridge and Temasek get 100 % return from Matrix
Singapore’s Temasek Holdings and Newbridge Capital, which together hold a combined 38 percent stake in India’s Matrix Laboratories, stand to make about 100 percent return on the pharmaceutical bet they made in May 2004.
